ABREXA PHARMACEUTICALS
Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease.
ABREXA PHARMACEUTICALS
Industry:
Health Care Pharmaceutical Service Industry
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(619) 295-5077
Total Funding:
7.63 M USD
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Employees Featured
Founder
More informations about "Abrexa Pharmaceuticals"
Abrexa Pharmaceuticals 2025 Company Profile: Valuation, Funding ...
Abrexa Pharmaceuticals General Information Description. Developer of novel drugs designed to treat Alzheimer's disease. The company's research capabilities are focused on developing the …See details»
Abrexa Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. 1282 Upas Street . San Diego, California, 92103, United States. 619-295-5077See details»
ABREXA PHARMACEUTICALS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ABREXA PHARMACEUTICALS, INC. of San Diego, CA. Get the latest business insights from Dun & …See details»
Abrexa Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Jan 23, 2025 Explore Abrexa Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 2 literature, Drug:J-147. ... The statistics for drugs in …See details»
Ernie Villafranca - CEO - Abrexa Pharmaceuticals, Inc. - LinkedIn
CEO at Abrexa Pharmaceuticals, Inc. · Experience: Abrexa Pharmaceuticals, Inc. · Location: San Diego · 176 connections on LinkedIn. ... REF is a global organization that brings together ...See details»
Abrexa Pharmaceuticals - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 25, 2018: Venture Round - …See details»
ABREXA PHARMACEUTICALS, INC | TREA
COMPOUNDS FOR PREVENTION AND TREATMENT OF POST-INTENSIVE CARE COGNI... Publication number 20210361598; Publication date Nov 25, 2021; Abrexa Pharmaceuticals, …See details»
Abrexa Pharmaceuticals, Inc. - Patsnap
Abrexa Pharmaceuticals, Inc. is headquartered in United States California. Abrexa Pharmaceuticals, Inc. was founded in 2011. Abrexa Pharmaceuticals, Inc. has a total of 32 …See details»
Abrexa Pharmaceuticals - VentureRadar
Innovation Pharmaceuticals (kfa Cellceutix) USA Publicly Traded Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to …See details»
Abrexa Pharmaceuticals, Inc. in San Diego, California - EIN TaxId
Abrexa Pharmaceuticals, Inc. is a corporation in San Diego, California. The employer identification number (EIN) for Abrexa Pharmaceuticals, Inc. is 453074039. EIN for organizations is …See details»
Abrexa Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Abrexa Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Abrexa …See details»
ABREXA PHARMACEUTICALS, INC. - US Patent and Trademark …
Abrexa Pharmaceuticals, Inc. of DELAWARE uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and …See details»
ABREXA PHARMACEUTICALS, INC. Top 13F Holdings
ABREXA PHARMACEUTICALS, INC. 1282 UPAS STREET SAN DIEGO CA 92103 Business Phone: (619) 295-5077. Recent SEC Filings. Filing Date; D/A: 2019-02-07: D: 2018-08-08: D: …See details»
Abrexa Pharmaceuticals - New Drug Approvals
Sep 6, 2019 Abrexa Pharmaceuticals is developing the oral curcumin derivative J-147 for the treatment of Alzheimer’s disease. A phase I clinical trial is under way in healthy young and …See details»
Abrexa Pharmaceuticals - Crunchbase
Abrexa Pharmaceuticals is a developer of drugs designed to treat Alzheimer disease. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Abrexa Pharmaceuticals - CB Insights
Abrexa Pharmaceuticals has 2 board of directors, including Eckard Weber. Name. Firm. Work History. Other Seats. Eckard Weber. Eckard joined Domain in 2001 as a partner and became …See details»
Abrexa Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
Aug 8, 2018 Abrexa Pharmaceuticals has raised $17.13M over 2 rounds. Abrexa Pharmaceuticals's latest funding round was a Series A for $16.63M on August 8, 2018. Date. …See details»
Abrexa Pharmaceuticals Stock Data, Filings, Earnings, News
Feb 7, 2023 Get the latest news, data and filings for Abrexa Pharmaceuticals, with free alerts. Includes transcripts, social sentiment, and more.See details»
J-147 - Drug Targets, Indications, Patents - Synapse - Patsnap
Mar 20, 2025 Abrexa Pharmaceuticals, Inc. [+1] 100 Clinical Results associated with J-147. Login to view more data. ... Organization Date; Alzheimer Disease: Phase 1: United States . …See details»